The epidemiology of fatty liver
- PMID: 15489565
- DOI: 10.1097/00042737-200411000-00002
The epidemiology of fatty liver
Abstract
There are insufficient data available on the epidemiology of fatty liver to design a complete and correct view of the prevalence, incidence and natural history of this disorder. This article, mainly based on the revision of recently published papers in this field, attempts to give an overview of the current findings on the epidemiology of fatty liver worldwide. The possible factors involved in the development of fat accumulation in the liver, and their potential role in the progression of the disorder will be also addressed.
Similar articles
-
Epidemiology and natural history of NAFLD and NASH.Clin Liver Dis. 2007 Feb;11(1):1-16, vii. doi: 10.1016/j.cld.2007.02.009. Clin Liver Dis. 2007. PMID: 17544968 Review.
-
Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.Semin Liver Dis. 2007 Aug;27(3):312-8. doi: 10.1055/s-2007-985075. Semin Liver Dis. 2007. PMID: 17682977 Review.
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30. Aliment Pharmacol Ther. 2011. PMID: 21623852 Review.
-
[Epidemiology and natural history of nonalcoholic fatty liver disease].Rev Prat. 2012 Dec;62(10):1416-8, 1420-1. Rev Prat. 2012. PMID: 23424924 Review. French.
-
Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.Mod Pathol. 2003 Jan;16(1):49-56. doi: 10.1097/01.MP.0000042420.21088.C7. Mod Pathol. 2003. PMID: 12527713
Cited by
-
Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery.Arch Endocrinol Metab. 2023 Nov 10;68:e220138. doi: 10.20945/2359-4292-2022-0138. Arch Endocrinol Metab. 2023. PMID: 37948562 Free PMC article.
-
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease.Front Pharmacol. 2022 Sep 16;13:1005312. doi: 10.3389/fphar.2022.1005312. eCollection 2022. Front Pharmacol. 2022. PMID: 36188561 Free PMC article. Review.
-
Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard.Ultrasonography. 2020 Jan;39(1):70-78. doi: 10.14366/usg.19002. Epub 2019 Jun 25. Ultrasonography. 2020. PMID: 31639886 Free PMC article.
-
The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study.Therap Adv Gastroenterol. 2019 Jun 23;12:1756284819858039. doi: 10.1177/1756284819858039. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31258620 Free PMC article.
-
Diagnostic and prognostic biomarkers for the screening of patients with metabolic liver disease risk.Germs. 2018 Dec 3;8(4):175-177. doi: 10.18683/germs.2018.1150. eCollection 2018 Dec. Germs. 2018. PMID: 30775335 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
